154 related articles for article (PubMed ID: 9423163)
1. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres.
Batycky RP; Hanes J; Langer R; Edwards DA
J Pharm Sci; 1997 Dec; 86(12):1464-77. PubMed ID: 9423163
[TBL] [Abstract][Full Text] [Related]
2. Elevated temperature accelerated release testing of PLGA microspheres.
Zolnik BS; Leary PE; Burgess DJ
J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
[TBL] [Abstract][Full Text] [Related]
3. Determinants of release rate of tetanus vaccine from polyester microspheres.
Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
[TBL] [Abstract][Full Text] [Related]
4. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
5. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
Zhao A; Rodgers VG
J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
[TBL] [Abstract][Full Text] [Related]
6. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
Murty SB; Goodman J; Thanoo BC; DeLuca PP
AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
[TBL] [Abstract][Full Text] [Related]
7. PLG microsphere size controls drug release rate through several competing factors.
Berkland C; Kim K; Pack DW
Pharm Res; 2003 Jul; 20(7):1055-62. PubMed ID: 12880292
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of PLGA microparticles: from polymer degradation to drug release.
Casalini T; Rossi F; Lazzari S; Perale G; Masi M
Mol Pharm; 2014 Nov; 11(11):4036-48. PubMed ID: 25230105
[TBL] [Abstract][Full Text] [Related]
9. Derivation of an Analytical Solution to a Reaction-Diffusion Model for Autocatalytic Degradation and Erosion in Polymer Microspheres.
Ford Versypt AN; Arendt PD; Pack DW; Braatz RD
PLoS One; 2015; 10(8):e0135506. PubMed ID: 26284787
[TBL] [Abstract][Full Text] [Related]
10. A potential approach for decreasing the burst effect of protein from PLGA microspheres.
Fu K; Harrell R; Zinski K; Um C; Jaklenec A; Frazier J; Lotan N; Burke P; Klibanov AM; Langer R
J Pharm Sci; 2003 Aug; 92(8):1582-91. PubMed ID: 12884245
[TBL] [Abstract][Full Text] [Related]
11. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
12. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
13. Use of thermodynamic parameters for design of double-walled microsphere fabrication methods.
Pollauf EJ; Pack DW
Biomaterials; 2006 May; 27(14):2898-906. PubMed ID: 16439013
[TBL] [Abstract][Full Text] [Related]
14. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.
Pollauf EJ; Berkland C; Kim KK; Pack DW
Int J Pharm; 2005 Sep; 301(1-2):294-303. PubMed ID: 16051452
[TBL] [Abstract][Full Text] [Related]
15. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
16. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior.
Astaneh R; Erfan M; Moghimi H; Mobedi H
J Pharm Sci; 2009 Jan; 98(1):135-45. PubMed ID: 18493999
[TBL] [Abstract][Full Text] [Related]
17. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.
Gupta RK; Chang AC; Griffin P; Rivera R; Guo YY; Siber GR
Vaccine; 1997; 15(6-7):672-8. PubMed ID: 9178469
[TBL] [Abstract][Full Text] [Related]
18. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
19. A Mechanistic Model for Acidic Drug Release Using Microspheres Made of PLGA 50:50.
Sevim K; Pan J
Mol Pharm; 2016 Aug; 13(8):2729-35. PubMed ID: 27398973
[TBL] [Abstract][Full Text] [Related]
20. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
